Use of antiplatelet agents is associated with intraplaque hemorrhage on carotid magnetic resonance imaging: The plaque at risk study

Stroke

Volumn 46, Issue 12, 2015, Pages 3411-3415

  Liem, Madieke I ^a   Schreuder, Floris H B M ^b,c   Van Dijk, Anouk C ^d   De Rotte, Alexandra A J ^e   Truijman, Martine T B ^b,c   Daemen, Mat J A P ^a   Van Der Steen, Anton F W ^d   Hendrikse, Jeroen ^e   Nederveen, Aart J ^a   Van Der Lugt, Aad ^d   Kooi, M Eline ^b   Nederkoorn, Paul J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

carotid stenosis; ischemic attack, transient; magnetic resonance imaging; risk factors; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; COUMARIN DERIVATIVE; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CAROTID ARTERY; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID INTRAPLAQUE HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; IMAGING SOFTWARE; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; CAROTID STENOSIS; CHEMICALLY INDUCED; CLINICAL TRIAL; HEMORRHAGE; METABOLISM; MIDDLE AGED; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; RISK FACTOR;

AGED; CAROTID ARTERIES; CAROTID STENOSIS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84948064972     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.008906     Document Type: Article

References (17)

1. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM., Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006 113 2320 2328. doi: 10.1161/CIRCULATIONAHA.105.589044.
2. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004 292 1845 1852. doi: 10.1001/jama.292.15.1845.
3. Gupta A, Baradaran H, Schweitzer AD, Kamel H, Pandya A, Delgado D, Carotid plaque MRI and stroke risk: a systematic review and meta-Analysis. Stroke 2013 44 3071 3077. doi: 10.1161/STROKEAHA.113.002551.
4. Nicolaides AN, Kakkos SK, Kyriacou E, Griffin M, Sabetai M, Thomas DJ, Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg 2010 52 1486 1496.e1. doi: 10.1016/j.jvs.2010.07.021.
5. Saam T, Hetterich H, Hoffmann V, Yuan C, Dichgans M, Poppert H, Meta-Analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol 2013 62 1081 1091. doi: 10.1016/j.jacc.2013.06.015.
6. AbuRahma AF, Boland JP, Robinson P, Decanio R., Antiplatelet therapy and carotid plaque hemorrhage and its clinical implications. J Cardiovasc Surg (Torino) 1990 31 66 70
7. Derksen WJ, Peeters W, Tersteeg C, de Vries JP, de Kleijn DP, Moll FL, Age and coumarin-Dype anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: a large histopathological study in carotid and femoral plaques. Atherosclerosis 2011 214 139 143. doi: 10.1016/j.atherosclerosis.2010.10.022.
8. Kwee RM, van Oostenbrugge RJ, Prins MH, Ter Berg JW, Franke CL, Korten AG, Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke 2010 41 1389 1393. doi: 10.1161/STROKEAHA.109.575670.
9. van den Bouwhuijsen QJ, Vernooij MW, Hofman A, Krestin GP, van der Lugt A, Witteman JC., Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. Eur Heart J 2012 33 221 229. doi: 10.1093/eurheartj/ehr227.
10. Truijman MT, Kooi ME, van Dijk AC, de Rotte AA, van der Kolk AG, Liem MI, Plaque At RISK (PARISK): prospective multicenter study to improve diagnosis of high-risk carotid plaques. Int J Stroke 2014 9 747 754. doi: 10.1111/ijs.12167.
11. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke 1991 22 711 720
12. Cappendijk VC, Cleutjens KB, Heeneman S, Schurink GW, Welten RJ, Kessels AG, In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging 2004 20 105 110. doi: 10.1002/jmri.20060.
13. Li X, Vink A, Niessen HW, Kers J, de Boer OJ, Ploegmakers HJ, Total burden of intraplaque hemorrhage in coronary arteries relates to the use of coumarin-Dype anticoagulants but not platelet aggregation inhibitors. Virchows Arch 2014 465 723 729. doi: 10.1007/s00428-014-1654-y.
14. Sandercock PA, Counsell C, Tseng MC, Cecconi E., Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2014 3 CD000029. doi: 10.1002/14651858.CD000029.pub3.
15. Hicks CW, Talbott K, Canner JK, Qazi U, Arhuidese I, Glebova NO, Risk of disease progression in patients with moderate asymptomatic carotid artery stenosis: implications of tobacco use and dual antiplatelet therapy. Ann Vasc Surg 2015 29 1 8. doi: 10.1016/j.avsg.2014.02.007.
16. European Carotid Surgery Trialists' Collaborative Group Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998 351 1379 1387
17. North American Symptomatic Carotid Endarterectomy Trial Collaborators Benefit of carotid endarterectomy in-patients with symptomatic, moderate or severe stenosis. NEJM 1998 339 1415 1425